Grade 3 Follicular Lymphoma — Trials

Grade 3 Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

214 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 50
Recruiting: 21
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: City of Hope Medical Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 101–109 of 109 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00054639	Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma	completed	Phase 2	48	National Cancer Institute (NCI)NIH	1	May 28, 2014	clinicaltrials
NCT00058019	Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma	completed	Phase 2	51	National Cancer Institute (NCI)NIH	1	May 23, 2014	clinicaltrials